Development of Practice Guideline using Yogic Health Promotion for Pregnant Women

Abstract

          This developmental research aimed to develop the practice guideline using yogic health promotion for pregnant women. Researchers applied the concepts for developing clinical practice guidelines of the National Health and Medical Council Australia (National Health and Medical Research Council: NHMRC, 1998). This was divided into 2 phases. The first phase, development practice phase, consisted of 5 steps. The second phase, periodically check the practice phase, consisted of 2 steps: content validity by 3 experts and evaluate its performance in use with 10 nurses in antenatal care unit. and nurses  responsibilities of maternal and child  of  Health Promotion Hospital.

          The results showed that the practice guideline using yogic health promotion for pregnant women composed of 1) practice guideline using yogic health promotion for normal pregnant women including 1.1) assessment of pregnant women and, 1.2) suggestion of  using yogic health promotion for pregnant women in the first trimester, the second trimester, and the third trimester, 2) practice guideline using yogic health promotion for high risk pregnant women is divided into 2.1) assessment of high risk pregnant women and 2.2) suggestion of  using yogic health promotion for high risk pregnant women (pregnancy induced hypertension and gestational diabetes mellitus). The detection of highly qualified content validity index from experts was 0.82. The effectiveness of application of this practice guideline was evaluated by comparison of the planning percentage health promotion activities with yoga to pregnant women and practicing to pregnant women at a high level (100 percent).

          The results of this research showed that the developed practice guideline could be used to promote healthy pregnancy with yoga. However, on outcome evaluation for testing the effectiveness of the practice guideline using yogic health promotion for pregnant women is recommended with normal and high-risk pregnant women.